<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35741206</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4418</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>05</Day></PubDate></JournalIssue><Title>Diagnostics (Basel, Switzerland)</Title><ISOAbbreviation>Diagnostics (Basel)</ISOAbbreviation></Journal><ArticleTitle>Predictors for COVID-19 Complete Remission with HRCT Pattern Evolution: A Monocentric, Prospective Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1397</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/diagnostics12061397</ELocationID><Abstract><AbstractText>There are growing concerns that some COVID-19 survivors may acquire fibrosis and other irreversible lung abnormalities. The purpose of this prospective study was to assess the rate and predictors of complete resolution of COVID-19 pneumonia by pursuing a hypothetical relation between time and imaging pattern evolution using HRCT findings. A monocentric prospective cohort study with a consecutive-case enrolment design was implemented during a five-month period, having a total of 683 post-COVID patients eligible for inclusion and 635 evaluations with complete follow-up for chest HRCT. The target for post-COVID evaluations consisted of performing HRCT 90 days after a confirmed SARS-CoV-2 infection. The studied patients had an average age of 54 years, ranging between 18 and 85 years old, and an average duration from the first symptoms until HRCT was performed of 74 days. At the post-COVID follow-up, 25.8% had a complete imagistic remission. The most common appearance with HRCT was &#x201c;ground glass&#x201d; in 86.6% in patients with persistent COVID-19, followed by reticulations, present in 78.8%, and respectively pleural thickening in 41.2% of cases. The mean total HRCT scores were statistically significantly higher in patients older than 65 years (10.6 &#xb1; 6.0) compared to the 40&#x2212;65 group (6.1 &#xb1; 6.1) and the 18&#x2212;40 age group (2.7 &#xb1; 4.8) (p &lt; 0.001). Chest HRCT is a &#x201c;time window&#x201d; in documenting temporal persistent radiologic features of lung injury 90 days after SARS-CoV-2 infection, determining the pathologic basis of so-called &#x201c;long COVID&#x201d;. The complete remission was associated with a significantly higher average follow-up period and a significantly lower average patient age. Persistent HRCT features of ground glass, reticulation, and pleural thickening are associated with a higher total CT score and older age.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Manolescu</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Radiology, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research and Innovation in Precision Medicine of Respiratory Diseases, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Timar</LastName><ForeName>Bogdan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Division of Diabetes, Nutrition and Metabolic Diseases, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bratosin</LastName><ForeName>Felix</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-4711-4315</Identifier><AffiliationInfo><Affiliation>Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosca</LastName><ForeName>Ovidiu</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Citu</LastName><ForeName>Cosmin</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-3730-6527</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oancea</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2083-0581</Identifier><AffiliationInfo><Affiliation>Center for Research and Innovation in Precision Medicine of Respiratory Diseases, "Victor Babes" University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diagnostics (Basel)</MedlineTA><NlmUniqueID>101658402</NlmUniqueID><ISSNLinking>2075-4418</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">HRCT</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">disease remission</Keyword><Keyword MajorTopicYN="N">imaging studies</Keyword><Keyword MajorTopicYN="N">prediction model</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35741206</ArticleId><ArticleId IdType="pmc">PMC9221666</ArticleId><ArticleId IdType="doi">10.3390/diagnostics12061397</ArticleId><ArticleId IdType="pii">diagnostics12061397</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mohanty S.K., Satapathy A., Naidu M.M., Mukhopadhyay S., Sharma S., Barton L.M., Stroberg E., Duval E.J., Pradhan D., Tzankovet A., et al. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)&#x2014;anatomic pathology perspective on current knowledge. Diagn. Pathol. 2020;15:103. doi: 10.1186/s13000-020-01017-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13000-020-01017-8</ArticleId><ArticleId IdType="pmc">PMC7427697</ArticleId><ArticleId IdType="pubmed">32799894</ArticleId></ArticleIdList></Reference><Reference><Citation>Cucinotta D., Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91:157&#x2013;160. doi: 10.23750/abm.v91i1.9397.</Citation><ArticleIdList><ArticleId IdType="doi">10.23750/abm.v91i1.9397</ArticleId><ArticleId IdType="pmc">PMC7569573</ArticleId><ArticleId IdType="pubmed">32191675</ArticleId></ArticleIdList></Reference><Reference><Citation>Adam D. The pandemic&#x2019;s true death toll: Millions more than official counts. Nature. 2022;601:312&#x2013;315. doi: 10.1038/d41586-022-00104-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-00104-8</ArticleId><ArticleId IdType="pubmed">35042997</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes-Pacheco M., Silva P.L., Cruz F.F., Battaglini D., Robba C., Pelosi P., Morales M.M., Neves C.C., Rocco P.R.M. Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies. Front. Physiol. 2021;12:593223. doi: 10.3389/fphys.2021.593223.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.593223</ArticleId><ArticleId IdType="pmc">PMC7876335</ArticleId><ArticleId IdType="pubmed">33584343</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokhtari T., Hassani F., Ghaffari N., Ebrahimi B., Yarahmadi A., Hassanzadeh G. COVID-19 and multiorgan failure: A narrative review on potential mechanisms. J. Mol. Histol. 2020;51:613&#x2013;628. doi: 10.1007/s10735-020-09915-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10735-020-09915-3</ArticleId><ArticleId IdType="pmc">PMC7533045</ArticleId><ArticleId IdType="pubmed">33011887</ArticleId></ArticleIdList></Reference><Reference><Citation>Vad&#xe1;sz I., Husain-Syed F., Dorfm&#xfc;ller P., Roller F.C., Tello K., Hecker M., Morty R.E., Gattenl&#xf6;hner S., Walmrath H.D., Grimminger F., et al. Severe organising pneumonia following COVID-19. Thorax. 2021;76:201&#x2013;204. doi: 10.1136/thoraxjnl-2020-216088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216088</ArticleId><ArticleId IdType="pubmed">33177230</ArticleId></ArticleIdList></Reference><Reference><Citation>Pannone G., Caponio V.C.A., De Stefano I.S., Ramunno M.A., Meccariello M., Agostinone A., Pedicillo M.C., Troiano G., Zhurakivska K., Cassano T., et al. Lung histopathological findings in COVID-19 disease&#x2014;A systematic review. Infect. Agent. Cancer. 2021;16:34. doi: 10.1186/s13027-021-00369-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13027-021-00369-0</ArticleId><ArticleId IdType="pmc">PMC8127295</ArticleId><ArticleId IdType="pubmed">34001199</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthay M.A., Zemans R.L. The acute respiratory distress syndrome: Pathogenesis and treatment. Annu. Rev. Pathol. 2011;6:147&#x2013;163. doi: 10.1146/annurev-pathol-011110-130158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathol-011110-130158</ArticleId><ArticleId IdType="pmc">PMC3108259</ArticleId><ArticleId IdType="pubmed">20936936</ArticleId></ArticleIdList></Reference><Reference><Citation>Poerio A., Carlicchi E., Lotrecchiano L., Pratic&#xf2; C., Mist&#xe8; G., Scavello S., Morsiani M., Zompatori M., Ferrari R. Evolution of COVID-19 Pulmonary Fibrosis-Like Residual Changes Over Time&#x2014;Longitudinal Chest CT up to 9 Months After Disease Onset: A Single-Center Case Series. SN Compr. Clin. Med. 2022;4:57. doi: 10.1007/s42399-022-01140-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-022-01140-1</ArticleId><ArticleId IdType="pmc">PMC8852861</ArticleId><ArticleId IdType="pubmed">35194572</ArticleId></ArticleIdList></Reference><Reference><Citation>de Paula C.B.V., Nagashima S., Liberalesso V., Collete M., da Silva F.P.G., Oricil A.G.G., Barbosa G.S., da Silva G.V.C., Wiedmer D.B., Dezid&#xe9;rio F.d., et al. COVID-19: Immunohistochemical Analysis of TGF-&#x3b2; Signaling Pathways in Pulmonary Fibrosis. Int. J. Mol. Sci. 2021;23:168. doi: 10.3390/ijms23010168.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23010168</ArticleId><ArticleId IdType="pmc">PMC8745764</ArticleId><ArticleId IdType="pubmed">35008594</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai D.K., Sharma P., Kumar R. Post COVID 19 pulmonary fibrosis. Is it real threat? Indian J. Tuberc. 2021;68:330&#x2013;333. doi: 10.1016/j.ijtb.2020.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijtb.2020.11.003</ArticleId><ArticleId IdType="pmc">PMC7654356</ArticleId><ArticleId IdType="pubmed">34099197</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Shen C., Wang L., Majumder S., Zhang D., Deen M.J., Li Y., Qing L., Zhang Y., Chen C., et al. Pulmonary fibrosis and its related factors in discharged patients with new corona virus pneumonia: A cohort study. Respir. Res. 2021;22:203. doi: 10.1186/s12931-021-01798-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-021-01798-6</ArticleId><ArticleId IdType="pmc">PMC8267229</ArticleId><ArticleId IdType="pubmed">34243776</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdi N.A., Ghadery A.H., SeyedAlinaghi S., Jafari F., Jafari S., Hasannezad M., Koochak H.E., Salehi M., Manshadi S.A.D., Meidani M., et al. Predictors of the chest CT score in COVID-19 patients: A cross-sectional study. Virol. J. 2021;18:225. doi: 10.1186/s12985-021-01699-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-021-01699-6</ArticleId><ArticleId IdType="pmc">PMC8600490</ArticleId><ArticleId IdType="pubmed">34794467</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan X., Yao L., Tan Y., Shen Z., Zheng H., Zhou H., Gao Y., Li Y., Ji W., Zhang H., et al. Quantitative and semiquantitative CT assessments of lung lesion burden in COVID-19 pneumonia. Sci. Rep. 2021;11:5148. doi: 10.1038/s41598-021-84561-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84561-7</ArticleId><ArticleId IdType="pmc">PMC7933172</ArticleId><ArticleId IdType="pubmed">33664342</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R., Li X., Liu H., Zhen Y., Zhang X., Xiong Q., Luo Y., Gao C., Zeng W. Chest CT Severity Score: An Imaging Tool for Assessing Severe COVID-19. Radiol. Cardiothorac. Imaging. 2020;30:e200047. doi: 10.1148/ryct.2020200047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/ryct.2020200047</ArticleId><ArticleId IdType="pmc">PMC7233443</ArticleId><ArticleId IdType="pubmed">33778560</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon J.J., Heyman B., Ko J.P., Condos R., Lynch D.A. CT of Post-Acute Lung Complications of COVID-19. Radiology. 2021;301:E383&#x2013;E395. doi: 10.1148/radiol.2021211396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021211396</ArticleId><ArticleId IdType="pmc">PMC8369881</ArticleId><ArticleId IdType="pubmed">34374591</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X., Fan Y., Alwalid O., Li N., Jia X., Yuan M., Li Y., Cao Y., Gu J., Wu H., et al. Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia. Radiology. 2021;299:E177&#x2013;E186. doi: 10.1148/radiol.2021203153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021203153</ArticleId><ArticleId IdType="pmc">PMC7841877</ArticleId><ArticleId IdType="pubmed">33497317</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Zhou H., Zhou Y., Wu X., Zhao Y., Lu Y., Tan W., Yuan M., Ding X., Zou J., et al. Temporal radiographic changes in COVID-19 patients: Relationship to disease severity and viral clearance. Sci. Rep. 2020;10:10263. doi: 10.1038/s41598-020-66895-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-66895-w</ArticleId><ArticleId IdType="pmc">PMC7314788</ArticleId><ArticleId IdType="pubmed">32581324</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Wang X., Dong J., Nie D., Chen Q., Yang F., Chen W. Temporal lung changes in high-resolution chest computed tomography for coronavirus disease 2019. J. Int. Med. Res. 2020;48:300060520950990. doi: 10.1177/0300060520950990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060520950990</ArticleId><ArticleId IdType="pmc">PMC7506184</ArticleId><ArticleId IdType="pubmed">32951493</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasin R., Gouda W. Chest X-ray findings monitoring COVID-19 disease course and severity. Egypt. J. Radiol. Nucl. Med. 2020;51:193. doi: 10.1186/s43055-020-00296-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43055-020-00296-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozturk S., Ozturk E.K., Kaya S.Y. Clinical and radiological characteristics of COVID-19 patients without comorbidities: A single-center study. Wien. Klin. Wochenschr. 2021;133:875&#x2013;881. doi: 10.1007/s00508-021-01880-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-021-01880-5</ArticleId><ArticleId IdType="pmc">PMC8173504</ArticleId><ArticleId IdType="pubmed">34081191</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Dong C., Hu Y., Li C., Ren Q., Zhang X., Shi H., Zhou M. Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study. Radiology. 2020;296:E55&#x2013;E64. doi: 10.1148/radiol.2020200843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020200843</ArticleId><ArticleId IdType="pmc">PMC7233482</ArticleId><ArticleId IdType="pubmed">32191587</ArticleId></ArticleIdList></Reference><Reference><Citation>Irizato N., Matsuura H., Okada A., Ueda K., Yamamura H. Serial computed tomography findings of Coronavirus disease 2019 (COVID-19) pneumonia treated with favipiravir and steroid therapy: Report of 11 cases. Bull. Natl. Res. Cent. 2021;45:92. doi: 10.1186/s42269-021-00553-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42269-021-00553-7</ArticleId><ArticleId IdType="pmc">PMC8132027</ArticleId><ArticleId IdType="pubmed">34025112</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X., Xi X., Min X., Feng Z., Li B., Cai W., Fan C., Wang L., Xia L. Long-term chest CT follow-up in COVID-19 Survivors: 102-361 days after onset. Ann. Transl. Med. 2021;9:1231. doi: 10.21037/atm-21-1438.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-21-1438</ArticleId><ArticleId IdType="pmc">PMC8421980</ArticleId><ArticleId IdType="pubmed">34532368</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B., Tonkin J., Devaraj A., Philip K.E.J., Orton C.M., Desai S.R., Shah P.L. CT Lung Abnormalities after COVID-19 at 3 Months and 1 Year after Hospital Discharge. Radiology. 2022;303:444&#x2013;454. doi: 10.1148/radiol.2021211746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021211746</ArticleId><ArticleId IdType="pmc">PMC8515207</ArticleId><ArticleId IdType="pubmed">34609195</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>